PacBio Named Senior Party in USPTO Interference Involving VisiGen Patent
March 31, 2009
PacBio Named Senior Party in USPTO Interference Involving VisiGen Patent
PacBio and Life Technologies, which owns VisiGen, are developing potentially rivaling real-time, single-molecule sequencing platforms, and the interference shows they claim ownership to related IP.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pacific Biosciences Named Senior Party in Patent Interference with Life Technologies
March 25, 2009 / GenomeWeb Daily News - Life Tech Defeats VisiGen Stakeholders in Arbitration of Breach-of-Contract, Fraud Suit
November 15, 2011 / In Sequence - Life Tech Denies Breach-of-Contract Claims in Suit by Former Visigen CEO
January 19, 2010 / In Sequence - Paired Ends
November 2, 2010 / In Sequence - In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM
October 2, 2012 / In Sequence